image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Plus500

September 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 1409p
Plus500, which runs a leading technology platform to trade  online contracts for difference, reported sales of US$346.2m in the six months to June, which although ahead of expectations, was down 38% on the record breaking 2020 when extreme pandemic related market volatility provided helpful conditions. Nevertheless Plus on-boarded almost 137,000 new customers, albeit well below the 198,000 in H1 ’20.The US$30m acquisition of Cunningham, a technology trading platform for options and futures, which provides entry into the US market, completed on 20 July.Canaccord says Plus effectively created a rod for its own back with the record breaking eps of 471 cents in 2020 and a combination of high industry churn and becalmed ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X